sign101

256. Malmstrom M, Ahlner J, Carlsson C, Schmekel B. No effect of chinese
acupuncture on isocapnic hyperventilation with cold air in asthmatics,
measured with impulse oscillometry. Acupuncture.in Medicine.
2002;20(2-3):66-73.
257. Blackhall K, Appleton S, Cates CJ. Ionisers for chronic asthma (Cochrane
Review). In: The Cochrane Library, Issue 3, 2003. London: John Wiley
& Sons Ltd.
258. Warner JA, Marchant JL, Warner JO. A double blind trial of ionisers
in children with asthma sensitive to the house dust mite. Thorax
1993;48(4):330-3.
259. Holloway E, Ram FSF. Breathing exercises for asthma (Cochrane
Review). In: The Cochrane Library, Issue 3, 2001. London: John Wiley
& Sons Ltd.
260. Singh V, Wisniewski A, Britton J, Tattersfield A. Effect of yoga breathing
exercises (pranayama) on airway reactivity in subjects with asthma.
Lancet 1990;335(8702):1381-3.
261. Cooper S, Oborne J, Newton S, Harrison v, Thompson Coon J, Lewis
S, et al. Effect of two breathing exercises (Buteyko and pranayama) in
asthma: a randomised controlled trial. Thorax 2003;58(8):674-9.
262. McHugh P, Aitcheson F, Duncan B, Houghton F. Buteyko breathing
technique for asthma: An effective intervention. N Z Med J
2003;116(1187):U710.
263. Bowler SD, Green A, Mitchell CA. Buteyko breathing techniques in
asthma: a blinded randomised controlled trial. Med J Aust 1998;169(11-
12):575-8.
264. Opat AJ, Cohen MM, Bailey MJ, Abramson MJ. A clinical trial of the
Buteyko Breathing Technique in asthma as taught by a video. J Asthma
2000;37(7):557-64.
265. Huntley A, Ernst E. Herbal medicines for asthma: a systematic review.
Thorax 2000;55(11):925-9.
266. Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL. Ding
Chuan Tang, a Chinese herb decoction, could improve airway hyperresponsiveness
in stabilized asthmatic children: a randomized, doubleblind
clinical trial. Pediatr Allergy Immunol 2006;17(5):316-22.
267. Hsu CH, Lu CM, Chang TT. Efficacy and safety of modified Mai-
Men-Dong-Tang for treatment of allergic asthma. Pediatric Allergy &
Immunology 2005;16(1):76-81.
268. Linde K, Jobst KA. Homeopathy for chronic asthma (Cochrane Review).
In: The Cochrane Library, Issue 3, 2001. London: John Wiley & Sons
Ltd.
269. White A, Slade P, Hunt C, Hart A, Ernst E. Individualised homeopathy as
an adjunct in the treatment of childhood asthma: a randomised placebo
controlled trial. Thorax 2003;58(4):317-21.
270. Huntley A, White AR, Ernst E. Relaxation therapies for asthma: a
systematic review. Thorax 2002;57(2):127-31.
271. Hondras MA, Linde K, Jones AP. Manual therapy for asthma (Cochrane
Review). In: The Cochrane Library, Issue 3, 2001. London: John Wiley
& Sons Ltd.
272. Panton J, Barley EA. Family therapy for asthma in children (Cochrane
Review). In: The Cochrane Library, Issue 2, 2000. London: John Wiley
& Sons Ltd.
273. North of England Evidence Based Guideline Development Project.
The primary care management of asthma in adults. Newcastle upon
Tyne:: University of Newcastle upon Tyne, Centre for Health Services
Research; 1999.
274. Pharmacological management of asthma. Evidence table 4.2: ipratopium
bromide. Edinburgh: SIGN; 2002. Available from url: http://www.sign.
ac.uk/guidelines/published/support/guideline63/index.html
275. Dennis SM, Sharp SJ, vickers MR, Frost CD, Crompton GK, Barnes
PJ, et al. Regular inhaled salbutamol and asthma control: the TRUST
randomised trial. Therapy Working Group of the National Asthma Task
Force and the MRC General Practice Research Framework. Lancet
2000;355(9216):1675-9.
276. Walters EH, Walters J. Inhaled short acting beta2-agonist use in asthma:
regular versus as needed treatment (Cochrane Review). In: The Cochrane
Library, Issue 3, 2001. London: John Wiley & Sons Ltd.
277. Pharmacological management of asthma. Evidence table 4.1: inhaled
short acting beta 2 agonists. Edinburgh: SIGN; 2002. Available from url:
http://www.sign.ac.uk/guidelines/published/support/guideline63/index.
html
278. Pharmacological management of asthma. Evidence table 4.4a: inhaled
corticosteroid vs theophylline. Edinburgh: SIGN; 2002. Available from
url: http://www.sign.ac.uk/guidelines/published/support/guideline63/
index.html
279. Pharmacological management of asthma. Evidence table 4.4c: inhaled
corticosteroid vs leukotriene receptor antagonists. Edinburgh: SIGN;
2002. Available from url: http://www.sign.ac.uk/guidelines/published/
support/guideline63/index.html
280. Adams N, Bestall J, Jones PW. Inhaled fluticasone proprionate for
chronic asthma (Cochrane Review). In: The Cochrane Library, Issue 3,
2001. London: John Wiley & Sons Ltd.
281. Adams NP, Bestall JB, Jones PW. Inhaled beclometasone versus placebo
for chronic asthma (Cochrane Review). In: The Cochrane Library, Issue
3, 2001. London: John Wiley & Sons Ltd.
referenCes
282. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness
of prophylactic inhaled steroids in childhood asthma: a systemic review
of the literature. J Allergy Clin Immunol 1997;100(4):452-7.
283. Carlsen KCL SS, Kamin W, et al. The efficacy and safety of fluticasone
propionate in very young children with persistent asthma symptoms.
Respir Med 2005;99(11):1393-402.
284. Teper AM CA, Kofman CD, et al. Effects of Inhaled Fluticasone
Propionate in Children Less Than 2 Years Old with Recurrent Wheezing.
Pediatr Pulmonol 2004;37(2):111-5.
285. Teper AM KC, Szulman GA, et al. . Fluticasone improves pulmonary
function in children under 2 years old with risk factors for asthma. Am
J Respir Crit Care Med 2005;171(6):587-90.
286. Bisgaard H AD, Milanowski J, et al. . Twelve-month safety and efficacy
of inhaled fluticasone propionate in children aged 1 to 3 years with
recurrent wheezing. Pediatrics 2004;113(2):e87-94.
287. O’Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom
T, Svensson K, et al. Low dose inhaled budesonide and formoterol
in mild persistent asthma: the OPTIMA randomized trial.[comment].
American Journal of Respiratory & Critical Care Medicine. 2001;164(8
Pt 1):1392-7.
288. Pauwels RA PS, Busse WW, et al. Early intervention with budesonide
in mild persistent asthma: a randomised, double-blind trial. Lancet
2003;361(9363):1071-6.
289. Pharmacological management of asthma. Evidence table 4.7: high dose
step-down. Edinburgh: SIGN; 2002. Available from url: http://www.
sign.ac.uk/guidelines/published/support/guideline63/index.html
290. Hodges IGC, Netherway TA. Once-daily fluticasone propionate is as
effective as twice-daily treatment in stable, mild-to-moderate childhood
asthma. Clin Drug Invest. 2005;25(1):13-22.
291. Ram FS, Jones A, Fay JK. Primary care based clinics for asthma (Cochrane
Review). In: The Cochrane Library, Issue 1, 2003. London: John Wiley
& Sons Ltd.
292. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear
growth of children with asthma: a meta-analysis. Pediatrics 2000;106(1):
E8.
293. Dunlop KA, Carson DJ, Steen HJ, McGovern v, McNaboe J, Shields
MD. Monitoring growth in asthmatic children treated with high dose
inhaled glucocorticoids does not predict adrenal suppression. Arch Dis
Child 2004;89(8):713-6.
294. Bernstein D AD. Evaluation of tests of hypothalamic-pituitary-adrenal
axis function used to measure effects of inhaled corticosteroids. Ann
Allergy Asthma Immunol 2007;98(2):118-27.
295. Pharmacological management of asthma. Evidence table 4.25:
budesonide vs beclometasone. Edinburgh: 2002. Available from url:
http://www.sign.ac.uk/guidelines/published/support/guideline63/index.
html
296. Pharmacological management of asthma. Evidence table 4.15:
mometasone furoate dry powder inhalation evidence. Edinburgh: SIGN;
2002. Available from url: http://www.sign.ac.uk/guidelines/published/
support/guideline63/index.html
297. Boulet LP, Drollmann A, Magyar P, Timar M, Knight A, Engelstatter R,
et al. Comparative efficacy of once-daily ciclesonide and budesonide in
the treatment of persistent asthma. Respir Med 2006;100(5):785-94.
298. Buhl R, vinkler I, Magyar P, Gyori Z, Rybacki C, Middle Mv, et al.
Comparable efficacy of ciclesonide once daily versus fluticasone
propionate twice daily in asthma. Pulm Pharmacol Ther 2006;19(6):404-
12.
299. Niphadkar P, Jagannath K, Joshi JM, Awad N, Boss H, Hellbardt
S, et al. Comparison of the efficacy of ciclesonide 160 microg QD
and budesonide 200 microg BID in adults with persistent asthma: a
phase III, randomized, double-dummy, open-label study. Clin Ther
2005;27(11):1752-63.
300. Pearlman DS, Berger WE, Kerwin E, Laforce C, Kundu S, Banerji D.
Once-daily ciclesonide improves lung function and is well tolerated
by patients with mild-to-moderate persistent asthma. J Allergy Clin
Immunol 2005;116(6):1206-12.
301. Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D.
Ciclesonide, a novel inhaled steroid, does not affect hypothalamicpituitary-adrenal
axis function in patients with moderate-to-severe
persistent asthma. Chest 2005;128(3):1104-14.
302. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF,
Thomson NC. Efficacy of low and high dose inhaled corticosteroid in
smokers versus non-smokers with mild asthma. Thorax 2005;60(4):282-
7.
303. Salmeterol (Severant) and formoterol (Oxis) in asthma management.
Curr Probl Pharmacovigilanc 2003;29(5).
304. Edwards A SM. The clinical efficacy of inhaled nedocromil sodium
(Tilade) in the treatment of asthma. Eur Respir J 1993;6(1):35-41.
305. Pharmacological management of asthma. Evidence table 4.24a: Other
preventor therapies - Chromones in children aged 5-12. Edinburgh:
SIGN; 2005. Available from url: http://www.sign.ac.uk/guidelines/
published/support/guideline63/index.html
131